Genprex
在场
Genprex 是一家在股票代码 GNPX (US) 下上市的公司。
高管
查看带有其 19 名主要高管的组织结构图
Genprex 搜索最多的简介
- Ryan Confer, Director, President and Chief Executive Officer
- Jose Moreno, Director
- Brent Longnecker, Director
高管在Genprex变化
- Jose Moreno Toscano 曾任 Board Member, 现升职为 Non-Executive Chairman of the Board (新闻发布的2024五月14号).
- Rodney Varner, Chairman of the Board and Chief Executive Officer, 已经去世。我们深感遗憾 (新闻发布的2024五月9号).
- Ryan Confer 曾任 Chief Financial Officer, 现升职为 Director, President and Chief Executive Officer (新闻发布的2024五月9号).
创建提醒
跟踪 Genprex 的高管变动
生物技术
Genprex 拥有 2,327 家竞争者，其中包括 Eurofins (卢森堡)、Lonza (瑞士) 和 Biogen (美国(美洲))。
Popular M&A news in 生物技术
- Chromocell的新名称是Channel Therapeutics Corporation。 (公布2024十一月22号).
- Enveda Biosciences 刚刚宣布为 130 筹款数百万美元。 (公布2024十一月22号).
- Alentis Therapeutics 刚刚宣布为 181 筹款数百万美元。 (公布2024十一月20号).
生物技术 行业的其他推荐联系人
消息
Genprex 的最新新闻稿
- Genprex Inc | NASDAQ: GNPX | Gene Therapy Cancer
- Genprex Announces Formation of Mesothelioma Clinical Advisory Board - Genprex
- Press Releases Archives - Page 22 of 22 - Genprex
- Genprex Featured in CEO/CFO Magazine Discussing Novel Gene Therapies for Cancer and Diabetes - Genprex
- Genprex Collaborators to Present Positive Preclinical Data on the Use of Reqorsa® Gene Therapy at the 2024 EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics - Genprex
- Genprex Announces Plans to Launch Separate Company to Focus on the Development of Gene Therapy to Treat Type-1 and Type-2 Diabetes - Genprex
- Genprex to Present and Participate at Upcoming September Investor and Industry Conferences - Genprex
- September 2024 - Genprex
- Genprex Releases New Video Featuring Chief Medical Officer Discussing Positive Patient Outcomes in Two Lung Cancer Clinical Trials - Genprex
- August 2024 - Genprex
- View more press releases Close
通过电子邮件
